Search research articles
Contact Us
Filters
Showing results (111-120 of 132) with videos related to
Page
of 14
Sort By:
JAMA
|
April 6, 2024
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial
Richard M Martin, Emma L Turner, Grace J Young, et al.
Journal of Alzheimer'S Disease : JAD
|
July 18, 2022
Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer's Disease in Nordic Populations
Ehsan Motazedi, Weiqiu Cheng, Jesper Q Thomassen, et al.
Journal of Applied Clinical Medical Physics
|
March 19, 2026
Post hoc estimation of a quantitative restriction spectrum imaging biomarker for prostate cancer detection using conventional MRI
Deondre D Do, Christopher C Conlin, Aditya Bagrodia, et al.
European Urology Open Science
|
January 15, 2025
Advanced Restriction Imaging and Reconstruction Technology for Prostate Magnetic Resonance Imaging (ART-Pro): A Study Protocol for a Multicenter, Multinational Trial Evaluating Biparametric Magnetic Resonance Imaging and Advanced, Quantitative Diffusion Magnetic Resonance Imaging for the Detection of Prostate Cancer
Madison T Baxter, Christopher C Conlin, Aditya Bagrodia, et al.
European Urology Open Science
|
February 16, 2026
Deep Learning Artificial Intelligence and Restriction Spectrum Imaging for Patient-level Detection of Clinically Significant Prostate Cancer on Biparametric Magnetic Resonance Imaging
Yuze Song, Mariluz Rojo Domingo, Christopher C Conlin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 10, 2023
NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023
Kelvin A Moses, Preston C Sprenkle, Clinton Bahler, et al.
The Journal of Urology
|
June 24, 2025
Reply by Authors
Mariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
The Journal of Urology
|
May 16, 2025
Restriction Spectrum Imaging as a Quantitative Biomarker for Prostate Cancer With Reliable Positive Predictive Value
Mariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
April 17, 2026
Systematic effects of patient factors and scanner/protocol factors on a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancer
Deondre D Do, Mariluz Rojo Domingo, Christopher C Conlin, et al.
International Journal of Cancer
|
September 15, 2020
African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer
Roshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 132) with videos related to
Sort By:
Page
of 14
JAMA
|
April 6, 2024
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial
Richard M Martin, Emma L Turner, Grace J Young, et al.
Journal of Alzheimer'S Disease : JAD
|
July 18, 2022
Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer's Disease in Nordic Populations
Ehsan Motazedi, Weiqiu Cheng, Jesper Q Thomassen, et al.
Journal of Applied Clinical Medical Physics
|
March 19, 2026
Post hoc estimation of a quantitative restriction spectrum imaging biomarker for prostate cancer detection using conventional MRI
Deondre D Do, Christopher C Conlin, Aditya Bagrodia, et al.
European Urology Open Science
|
January 15, 2025
Advanced Restriction Imaging and Reconstruction Technology for Prostate Magnetic Resonance Imaging (ART-Pro): A Study Protocol for a Multicenter, Multinational Trial Evaluating Biparametric Magnetic Resonance Imaging and Advanced, Quantitative Diffusion Magnetic Resonance Imaging for the Detection of Prostate Cancer
Madison T Baxter, Christopher C Conlin, Aditya Bagrodia, et al.
European Urology Open Science
|
February 16, 2026
Deep Learning Artificial Intelligence and Restriction Spectrum Imaging for Patient-level Detection of Clinically Significant Prostate Cancer on Biparametric Magnetic Resonance Imaging
Yuze Song, Mariluz Rojo Domingo, Christopher C Conlin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 10, 2023
NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023
Kelvin A Moses, Preston C Sprenkle, Clinton Bahler, et al.
The Journal of Urology
|
June 24, 2025
Reply by Authors
Mariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
The Journal of Urology
|
May 16, 2025
Restriction Spectrum Imaging as a Quantitative Biomarker for Prostate Cancer With Reliable Positive Predictive Value
Mariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
April 17, 2026
Systematic effects of patient factors and scanner/protocol factors on a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancer
Deondre D Do, Mariluz Rojo Domingo, Christopher C Conlin, et al.
International Journal of Cancer
|
September 15, 2020
African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer
Roshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Page
of 14